Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Chronic Heart Failure

Free Subscription Articles published in Clin Cardiol Retrieve available abstracts of 86 articles: HTML format

Single Articles

March 2023
1. YIN C, Li J, Yuan L
   Comment on: Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta-analysis.
   Clin Cardiol. 2023 Mar 2. doi: 10.1002/clc.23994.
   PubMed    
   
   
   February 2023
2. CHEN W, Lin G, Dai C, Xu K, et al
   Predictive value of serum iron on heart failure in patients with acute ST-segment elevation myocardial infarction.
   Clin Cardiol. 2023 Feb 13. doi: 10.1002/clc.23990.
   PubMed     Abstract available
   
   
   January 2023
3. FREEDMAN BL, Berg DD, Scirica BM, Bohula EA, et al
   Response to Mei et al. regarding the incidence and predictors of hospitalization for heart failure among patients with stable atherosclerosis in the TRA 2 degrees P-TIMI 50 trial.
   Clin Cardiol. 2023 Jan 24. doi: 10.1002/clc.23972.
   PubMed    
   
   
   
4. MEI K, Ling Q, Gao Y, Liu X, et al
   Letter to the editor: Epidemiology of heart failure hospitalization in patients with stable atherothrombotic disease: The contribution of previous heart failure to heart failure hospitalization may be overestimated.
   Clin Cardiol. 2023 Jan 19. doi: 10.1002/clc.23973.
   PubMed    
   
   
   
5. ZHANG X, Sun Y, Li Y, Wang C, et al
   Association between visceral adiposity index and heart failure: A cross-sectional study.
   Clin Cardiol. 2023 Jan 18. doi: 10.1002/clc.23976.
   PubMed     Abstract available
   
   
   
6. CHEN WW, Jiang J, Gao J, Zhang XZ, et al
   Efficacy and safety of low-dose sacubitril/valsartan in heart failure patients: A systematic review and meta-analysis.
   Clin Cardiol. 2023 Jan 17. doi: 10.1002/clc.23971.
   PubMed     Abstract available
   
   
   
7. CHEN R, Xu J, Wang Y, Jiang B, et al
   Prevalence of sarcopenia and its association with clinical outcomes in heart failure: An updated meta-analysis and systematic review.
   Clin Cardiol. 2023 Jan 16. doi: 10.1002/clc.23970.
   PubMed     Abstract available
   
   
   December 2022
8. YANG Y, Wu D, Wang H, Wang Y, et al
   Prognostic value of global longitudinal strain in hypertrophic cardiomyopathy: A systematic review and meta-analysis.
   Clin Cardiol. 2022;45:1184-1191.
   PubMed     Abstract available
   
   
   November 2022
9. LIAO LP, Yang Y
   Response to letter to the editor entitled: "Correlation analysis of the triglyceride glucose index and heart failure with preserved ejection fraction in essential hypertensive patients".
   Clin Cardiol. 2022 Nov 20. doi: 10.1002/clc.23943.
   PubMed    
   
   
   
10. NAKAGAWA Y, Imamura T
    Clinical implication of ambulatory milrinone therapy in patients with advanced heart failure.
    Clin Cardiol. 2022 Nov 20. doi: 10.1002/clc.23953.
    PubMed    
    
    
    
11. HAO Z, Xu G, Yuan M, Sun Y, et al
    The predictive value of changes in left atrial volume index for rehospitalization in heart failure with preserved ejection fraction.
    Clin Cardiol. 2022 Nov 20. doi: 10.1002/clc.23952.
    PubMed     Abstract available
    
    
    
12. MEI K, Ling Q, Yan Z
    Correlation analysis of the triglyceride glucose index and heart failure with preserved ejection fraction in essential hypertensive patients.
    Clin Cardiol. 2022 Nov 20. doi: 10.1002/clc.23944.
    PubMed    
    
    
    
13. LEE HW, Huang CC, Yang CY, Leu HB, et al
    Renal function during hospitalization and outcome in Chinese patients with acute decompensated heart failure: A retrospective study and literature review.
    Clin Cardiol. 2022 Nov 7. doi: 10.1002/clc.23934.
    PubMed     Abstract available
    
    
    September 2022
14. HUANG B, Huang Y, Zhai M, Zhou Q, et al
    Prevalence, clinical characteristics, and predictors of sleep disordered breathing in hospitalized heart failure patients.
    Clin Cardiol. 2022 Sep 30. doi: 10.1002/clc.23925.
    PubMed     Abstract available
    
    
    
15. PICCIRILLO G, Moscucci F, Carnovale M, Bertani G, et al
    QT and Tpeak-Tend interval variability: Predictive electrical markers of hospital stay length and mortality in acute decompensated heart failure. Preliminary data.
    Clin Cardiol. 2022 Sep 9. doi: 10.1002/clc.23888.
    PubMed     Abstract available
    
    
    
16. BLAGOVA O, Lutokhina Y, Kogan E, Kukleva A, et al
    Chronic biopsy proven post-COVID myoendocarditis with SARS-Cov-2 persistence and high level of antiheart antibodies.
    Clin Cardiol. 2022;45:952-959.
    PubMed     Abstract available
    
    
    August 2022
17. AHLGRIM C, Seiler F, Birkner P, Schoechlin S, et al
    Clinically unrecognized plasma volume expansion predicts long-term all-cause-mortality in chronic heart failure.
    Clin Cardiol. 2022 Aug 3. doi: 10.1002/clc.23893.
    PubMed     Abstract available
    
    
    
18. SHANG W, Zhang Y, Han D
    Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta-analysis.
    Clin Cardiol. 2022 Aug 2. doi: 10.1002/clc.23889.
    PubMed     Abstract available
    
    
    July 2022
19. NAAMI R, Naami E, Omari T, Lowi SG, et al
    Cardiac rehabilitation performance predicts 1-year major adverse cardiovascular events.
    Clin Cardiol. 2022 Jul 29. doi: 10.1002/clc.23890.
    PubMed     Abstract available
    
    
    
20. LIU YX, Chen W, Lin X, Zhu YL, et al
    Initiating ivabradine during hospitalization in patients with acute heart failure: A real-world experience in China.
    Clin Cardiol. 2022 Jul 23. doi: 10.1002/clc.23880.
    PubMed     Abstract available
    
    
    
21. FREEDMAN BL, Berg DD, Scirica BM, Bohula EA, et al
    Epidemiology of heart failure hospitalization in patients with stable atherothrombotic disease: Insights from the TRA 2 degrees P-TIMI 50 trial.
    Clin Cardiol. 2022 Jul 19. doi: 10.1002/clc.23843.
    PubMed     Abstract available
    
    
    
22. VICTORIA-CASTRO AM, Martin M, Yamamoto Y, Ahmad T, et al
    Pragmatic randomized trial assessing the impact of digital health technology on quality of life in patients with heart failure: Design, rationale and implementation.
    Clin Cardiol. 2022 Jul 12. doi: 10.1002/clc.23848.
    PubMed     Abstract available
    
    
    
23. ZDANYTE M, Martus P, Nestele J, Bild A, et al
    Risk assessment in COVID-19: Prognostic importance of cardiovascular parameters.
    Clin Cardiol. 2022 Jul 5. doi: 10.1002/clc.23883.
    PubMed     Abstract available
    
    
    June 2022
24. LIAO LP, Yang Y, Wu Y, Li W, et al
    Correlation analysis of the triglyceride glucose index and heart failure with preserved ejection fraction in essential hypertensive patients.
    Clin Cardiol. 2022 Jun 29. doi: 10.1002/clc.23881.
    PubMed     Abstract available
    
    
    
25. NAKAGAWA Y, Imamura T
    Detailed association between the etiologies of heart failure and occurrence of sleep-disordered breathing.
    Clin Cardiol. 2022 Jun 22. doi: 10.1002/clc.23875.
    PubMed    
    
    
    
26. SCIRICA BM, Im K, Murphy SA, Kuder JF, et al
    Re-adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study-level meta-analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase-4 (DPP-4) inhibitors.
    Clin Cardiol. 2022 Jun 17. doi: 10.1002/clc.23844.
    PubMed     Abstract available
    
    
    
27. DEVORE AD, Bosworth HB, Granger BB
    Improving implementation of evidence-based therapies for heart failure.
    Clin Cardiol. 2022;45 Suppl 1:S52-S59.
    PubMed     Abstract available
    
    
    
28. TALHA KM, Butler J
    Breakthroughs in the treatment of heart failure with mildly reduced and preserved ejection fraction.
    Clin Cardiol. 2022;45 Suppl 1:S31-S39.
    PubMed     Abstract available
    
    
    
29. MCMURRAY JJV, Docherty KF
    Insights into foundational therapies for heart failure with reduced ejection fraction.
    Clin Cardiol. 2022;45 Suppl 1:S26-S30.
    PubMed     Abstract available
    
    
    
30. CHANDRAMOULI C, Stewart S, Almahmeed W, Lam CSP, et al
    Clinical implications of the universal definition for the prevention and treatment of heart failure.
    Clin Cardiol. 2022;45 Suppl 1:S2-S12.
    PubMed     Abstract available
    
    
    
31. FONAROW GC
    Advances in the management of heart failure.
    Clin Cardiol. 2022;45 Suppl 1:S1.
    PubMed    
    
    
    
32. OSTROMINSKI JW, Vaduganathan M
    Evolving therapeutic strategies for patients hospitalized with new or worsening heart failure across the spectrum of left ventricular ejection fraction.
    Clin Cardiol. 2022;45 Suppl 1:S40-S51.
    PubMed     Abstract available
    
    
    
33. HAMMOND MM, Everitt IK, Khan SS
    New strategies and therapies for the prevention of heart failure in high-risk patients.
    Clin Cardiol. 2022;45 Suppl 1:S13-S25.
    PubMed     Abstract available
    
    
    May 2022
34. LIANG L, Huang L, Zhao X, Zhao L, et al
    Prognostic value of RDW alone and in combination with NT-proBNP in patients with heart failure.
    Clin Cardiol. 2022 May 27. doi: 10.1002/clc.23850.
    PubMed     Abstract available
    
    
    
35. GU G, Wu J, Gao X, Liu M, et al
    Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction: A meta-analysis.
    Clin Cardiol. 2022 May 11. doi: 10.1002/clc.23841.
    PubMed     Abstract available
    
    
    
36. WANG T, Yu FC, Wei Q, Xu X, et al
    Sleep-disordered breathing in heart failure patients with different etiologies.
    Clin Cardiol. 2022 May 10. doi: 10.1002/clc.23840.
    PubMed     Abstract available
    
    
    
37. GUERRA F, D'Onofrio A, De Ruvo E, Manzo M, et al
    Decongestive treatment adjustments in heart failure patients remotely monitored with a multiparametric implantable defibrillators algorithm.
    Clin Cardiol. 2022 May 3. doi: 10.1002/clc.23832.
    PubMed     Abstract available
    
    
    April 2022
38. ROTH ME, Chinn ME, Dunn SP, Bilchick KC, et al
    Association of colchicine use for acute gout with clinical outcomes in acute decompensated heart failure.
    Clin Cardiol. 2022 Apr 28. doi: 10.1002/clc.23830.
    PubMed     Abstract available
    
    
    March 2022
39. DEL CID FRATTI J, Salazar M, Argueta-Sosa EE
    Vaccine-preventable disease hospitalized patients with heart failure with reduced ejection fraction.
    Clin Cardiol. 2022 Mar 10. doi: 10.1002/clc.23800.
    PubMed     Abstract available
    
    
    
40. LAUFER-PERL M, Sadon S, Zahler D, Milwidsky A, et al
    Repetitive milrinone therapy in ambulatory advanced heart failure patients.
    Clin Cardiol. 2022 Mar 4. doi: 10.1002/clc.23802.
    PubMed     Abstract available
    
    
    
41. WEN XS, Luo R, Liu J, Liu ZQ, et al
    The duration of beta-blocker therapy and outcomes in patients without heart failure or left ventricular systolic dysfunction after acute myocardial infarction: A multicenter prospective cohort study.
    Clin Cardiol. 2022 Mar 4. doi: 10.1002/clc.23807.
    PubMed     Abstract available
    
    
    
42. LEAHOVA-CERCHEZ X, Berthelot E, Genet B, Hanon O, et al
    Estimation of the plasma volume status of elderly patients with acute decompensated heart failure using bedside clinical, biological, and ultrasound parameters.
    Clin Cardiol. 2022 Mar 2. doi: 10.1002/clc.23791.
    PubMed     Abstract available
    
    
    February 2022
43. KRITTAYAPHONG R, Pumprueg S, Sairat P
    Soluble ST2 in the prediction of heart failure and death in patients with atrial fibrillation.
    Clin Cardiol. 2022 Feb 21. doi: 10.1002/clc.23799.
    PubMed     Abstract available
    
    
    
44. HOSEINI SG, Heshmat-Ghahdarijani K, Khosrawi S, Garakyaraghi M, et al
    Melatonin supplementation improves N-terminal pro-B-type natriuretic peptide levels and quality of life in patients with heart failure with reduced ejection fraction: Results from MeHR trial, a randomized clinical trial.
    Clin Cardiol. 2022 Feb 16. doi: 10.1002/clc.23796.
    PubMed     Abstract available
    
    
    
45. HWANG JW, Kim DG, Kim H, Kwak JJ, et al
    Impact of chronic kidney disease on clinical outcomes in patients with Stage B progressive aortic regurgitation (mild to moderate and moderate grades).
    Clin Cardiol. 2022 Feb 16. doi: 10.1002/clc.23792.
    PubMed     Abstract available
    
    
    
46. AMBROSY AP, Malik UI, Leong TK, Allen AR, et al
    Food security, diet quality, nutritional knowledge, and attitudes towards research in adults with heart failure during the COVID-19 pandemic.
    Clin Cardiol. 2022 Feb 2. doi: 10.1002/clc.23761.
    PubMed     Abstract available
    
    
    January 2022
47. PARK J, Zhong X, Babaie Sarijaloo F, Wokhlu A, et al
    Tailored risk assessment of 90-day acute heart failure readmission or all-cause death to heart failure with preserved versus reduced ejection fraction.
    Clin Cardiol. 2022 Jan 25. doi: 10.1002/clc.23780.
    PubMed     Abstract available
    
    
    
48. COOPER LB, Bruce S, Psotka M, Mentz R, et al
    Proteomic differences among patients with heart failure taking furosemide or torsemide.
    Clin Cardiol. 2022 Jan 11. doi: 10.1002/clc.23733.
    PubMed     Abstract available
    
    
    
49. LIANG M, Bian B, Yang Q
    Characteristics and long-term prognosis of patients with reduced, mid-range, and preserved ejection fraction: A systemic review and meta-analysis.
    Clin Cardiol. 2022;45:5-17.
    PubMed     Abstract available
    
    
    December 2021
50. KONIG S, Pellissier V, Leiner J, Hohenstein S, et al
    Expected and observed in-hospital mortality in heart failure patients before and during the COVID-19 pandemic: Introduction of the machine learning-based standardized mortality ratio at Helios hospitals.
    Clin Cardiol. 2021 Dec 23. doi: 10.1002/clc.23762.
    PubMed     Abstract available
    
    
    
51. KAPTEIN YE, Kaptein EM
    Comparison of subclavian vein to inferior vena cava collapsibility by ultrasound in acute heart failure: A pilot study.
    Clin Cardiol. 2021 Dec 21. doi: 10.1002/clc.23758.
    PubMed     Abstract available
    
    
    October 2021
52. EMMENS JE, Ter Maaten JM, Brouwers FP, Kieneker LM, et al
    Proenkephalin and the risk of new-onset heart failure: data from prevention of renal and vascular end-stage disease.
    Clin Cardiol. 2021 Oct 30. doi: 10.1002/clc.23729.
    PubMed     Abstract available
    
    
    
53. DIAO K, Wang D, Chen Z, Wu X, et al
    Rationale and design of a multi-center, prospective randomized controlled trial on the effects of sacubitril-valsartan versus enalapril on left ventricular remodeling in ST-elevation myocardial infarction: The PERI-STEMI study.
    Clin Cardiol. 2021 Oct 20. doi: 10.1002/clc.23744.
    PubMed     Abstract available
    
    
    
54. LI N, Zhu Y, Zeng J
    Clinical value of pulmonary congestion detection by lung ultrasound in patients with chronic heart failure.
    Clin Cardiol. 2021 Oct 1. doi: 10.1002/clc.23738.
    PubMed     Abstract available
    
    
    September 2021
55. PACHECO C, Wei J, Shufelt C, C Hitzeman T, et al
    Association of coronary microvascular dysfunction and cardiac bridge integrator 1, a cardiomyocyte dysfunction biomarker.
    Clin Cardiol. 2021 Sep 16. doi: 10.1002/clc.23726.
    PubMed     Abstract available
    
    
    
56. BEL HAJ ALI K, Sekma A, Nouira S
    Response to "practical implication of nitroglycerin test for diagnosing heart failure in emergency department".
    Clin Cardiol. 2021 Sep 13. doi: 10.1002/clc.23721.
    PubMed    
    
    
    August 2021
57. ZHAO J, Zeng Y, Shen X
    Efficacy and safety of early initiation of Sacubitril/Valsartan in patients after acute myocardial infarction: A meta-analysis.
    Clin Cardiol. 2021 Aug 31. doi: 10.1002/clc.23717.
    PubMed     Abstract available
    
    
    
58. HIROI S, Izumida T, Imamura T
    Practical implication of nitroglycerin test for diagnosing heart failure in emergency department.
    Clin Cardiol. 2021 Aug 29. doi: 10.1002/clc.23722.
    PubMed    
    
    
    
59. MCCULLOUGH PA, Mehta HS, Barker CM, Van Houten J, et al
    Mortality and guideline-directed medical therapy in real-world heart failure patients with reduced ejection fraction.
    Clin Cardiol. 2021 Aug 3. doi: 10.1002/clc.23664.
    PubMed     Abstract available
    
    
    
60. SU Y, Hua W, Shen F, Zou J, et al
    Left ventricular-only fusion pacing versus cardiac resynchronization therapy in heart failure patients: A randomized controlled trial.
    Clin Cardiol. 2021 Aug 3. doi: 10.1002/clc.23616.
    PubMed     Abstract available
    
    
    July 2021
61. OSHIMA A, Imamura T, Narang N, Kinugawa K, et al
    Management of hyperkalemia in chronic heart failure using sodium zirconium cyclosilicate.
    Clin Cardiol. 2021 Jul 15. doi: 10.1002/clc.23683.
    PubMed     Abstract available
    
    
    
62. ZHANG D, Lai W, Liu X, Shen Y, et al
    The safety of morphine in patients with acute heart failure: A systematic review and meta-analysis.
    Clin Cardiol. 2021 Jul 8. doi: 10.1002/clc.23691.
    PubMed     Abstract available
    
    
    June 2021
63. HOSEINI SG, Heshmat-Ghahdarijani K, Khosrawi S, Garakyaraghi M, et al
    Effect of melatonin supplementation on endothelial function in heart failure with reduced ejection fraction: A randomized, double-blinded clinical trial.
    Clin Cardiol. 2021 Jun 28. doi: 10.1002/clc.23682.
    PubMed     Abstract available
    
    
    
64. BEAUVAIS F, Tartiere L, Pezel T, Motet C, et al
    First symptoms and health care pathways in hospitalized patients with acute heart failure: ICPS2 survey. A report from the Heart Failure Working Group (GICC) of the French Society of Cardiology.
    Clin Cardiol. 2021 Jun 26. doi: 10.1002/clc.23666.
    PubMed     Abstract available
    
    
    
65. VAN WOERDEN G, van Veldhuisen DJ, Gorter TM, van Empel VPM, et al
    Importance of epicardial adipose tissue localization using cardiac magnetic resonance imaging in patients with heart failure with mid-range and preserved ejection fraction.
    Clin Cardiol. 2021 Jun 4. doi: 10.1002/clc.23644.
    PubMed     Abstract available
    
    
    
66. SEKMA A, Bel Haj Ali K, Jeddi C, Ben Brahim N, et al
    Value of nitroglycerin test in the diagnosis of heart failure in emergency department patients with undifferentiated dyspnea.
    Clin Cardiol. 2021 Jun 2. doi: 10.1002/clc.23615.
    PubMed     Abstract available
    
    
    May 2021
67. TAKABAYASHI K, Kitaguchi S, Yamamoto T, Takenaka K, et al
    Mode of death in elderly and super-elderly patients with acute heart failure: Insights from Japanese heart failure registry.
    Clin Cardiol. 2021 May 8. doi: 10.1002/clc.23619.
    PubMed     Abstract available
    
    
    
68. KOBAYASHI M, Voors AA, Ouwerkerk W, Duarte K, et al
    Perceived risk profile and treatment optimization in heart failure: an analysis from BIOlogy Study to TAilored Treatment in chronic heart failure.
    Clin Cardiol. 2021 May 7. doi: 10.1002/clc.23576.
    PubMed     Abstract available
    
    
    March 2021
69. WANG SJ, Cheng ZX, Fan XT, Lian YG, et al
    Development of an optimized risk score to predict short-term death among acute myocardial infarction patients in rural China.
    Clin Cardiol. 2021 Mar 25. doi: 10.1002/clc.23598.
    PubMed     Abstract available
    
    
    
70. NARANG N, Dela Cruz M, Imamura T, Chung B, et al
    Discordance between lactic acidemia and hemodynamics in patients with advanced heart failure.
    Clin Cardiol. 2021 Mar 18. doi: 10.1002/clc.23584.
    PubMed     Abstract available
    
    
    
71. LAM CSP, Wood R, Vaduganathan M, Bueno H, et al
    Contemporary economic burden in a real-world heart failure population with Commercial and Medicare supplemental plans.
    Clin Cardiol. 2021 Mar 11. doi: 10.1002/clc.23585.
    PubMed     Abstract available
    
    
    February 2021
72. BRYAN RICHARD S, Huang B, Liu G, Yang Y, et al
    Impact of ivabradine on the cardiac function of chronic heart failure reduced ejection fraction: Meta-analysis of randomized controlled trials.
    Clin Cardiol. 2021 Feb 27. doi: 10.1002/clc.23581.
    PubMed     Abstract available
    
    
    
73. YAZAKI M, Nabeta T, Ako J
    Response to letter to the editor entitled "Association between left atrial sphericity index and clinical outcomes in patients with systolic heart failure".
    Clin Cardiol. 2021 Feb 8. doi: 10.1002/clc.23563.
    PubMed    
    
    
    
74. CHAPMAN M, Imamura T
    Association between left atrial sphericity index and clinical outcomes in patients with systolic heart failure.
    Clin Cardiol. 2021 Feb 4. doi: 10.1002/clc.23562.
    PubMed    
    
    
    January 2021
75. CHEN J, Yu P, Ma J, Zheng C, et al
    Does subclinical atrial fibrillation independently predict adverse outcomes in patients with heart failure and cardiac resynchronization therapy defibrillator.
    Clin Cardiol. 2021 Jan 19. doi: 10.1002/clc.23547.
    PubMed    
    
    
    
76. PANDEY AC, Jer D, Kuo RS, Yoo DH, et al
    Novel doses of sacubitril/valsartan in patients unable to tolerate traditional therapy: Effects on N-terminal pro B-type natriuretic peptide levels.
    Clin Cardiol. 2021;44:85-90.
    PubMed     Abstract available
    
    
    December 2020
77. LEE CJ, Ryu HY, Chun KH, Oh J, et al
    Association of muscular fitness with rehospitalization for heart failure with reduced ejection fraction.
    Clin Cardiol. 2020 Dec 25. doi: 10.1002/clc.23535.
    PubMed     Abstract available
    
    
    
78. SARIJALOO F, Park J, Zhong X, Wokhlu A, et al
    Predicting 90 day acute heart failure readmission and death using machine learning-supported decision analysis.
    Clin Cardiol. 2020 Dec 23. doi: 10.1002/clc.23532.
    PubMed     Abstract available
    
    
    November 2020
79. JOHANSEN ME, Argyropoulos C
    The cardiovascular outcomes, heart failure and kidney disease trials tell that the time to use Sodium Glucose Cotransporter 2 inhibitors is now.
    Clin Cardiol. 2020 Nov 9. doi: 10.1002/clc.23508.
    PubMed     Abstract available
    
    
    
80. MUK B, Vamos M, Bogyi P, Szabo B, et al
    The impact of serum concentration-guided digoxin therapy on mortality of heart failure patients: A long-term follow-up, propensity-matched cohort study.
    Clin Cardiol. 2020 Nov 3. doi: 10.1002/clc.23500.
    PubMed     Abstract available
    
    
    October 2020
81. SHENG CC, Sahoo D, Dugar S, Prada RA, et al
    Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study).
    Clin Cardiol. 2020;43:1055-1063.
    PubMed     Abstract available
    
    
    September 2020
82. ARAI S, Kawamura M, Gokan T, Yoshikawa K, et al
    Relationship between device-detected subclinical atrial fibrillation and heart failure in patients with cardiac resynchronization therapy defibrillator.
    Clin Cardiol. 2020 Sep 29. doi: 10.1002/clc.23471.
    PubMed     Abstract available
    
    
    May 2020
83. ZAMANI SK, Samuel TJ, Wei J, Thomson LEJ, et al
    Left atrial stiffness in women with ischemia and no obstructive coronary artery disease: Novel insight from left atrial feature tracking.
    Clin Cardiol. 2020 May 27. doi: 10.1002/clc.23395.
    PubMed     Abstract available
    
    
    
84. JENTZER JC, Wiley B, Bennett C, Murphree DH, et al
    Early noncardiovascular organ failure and mortality in the cardiac intensive care unit.
    Clin Cardiol. 2020;43:516-523.
    PubMed     Abstract available
    
    
    March 2020
85. MARINI M, Branzoli S, Moggio P, Martin M, et al
    Epicardial left ventricular lead implantation in cardiac resynchronization therapy patients via a video-assisted thoracoscopic technique: Long-term outcome.
    Clin Cardiol. 2020;43:284-290.
    PubMed     Abstract available
    
    
    December 2019
86. HESS PL, Matlock DD, Al-Khatib SM
    Decision-making regarding primary prevention implantable cardioverter-defibrillators among older adults.
    Clin Cardiol. 2019 Dec 23. doi: 10.1002/clc.23315.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: